To develop and optimize the world’s leading health and wellness ecosystem.
MVMD is building a world-class health and wellness organization centred around the implementation of patented oral delivery technologies to create industry leading products that are sought out globally.
Our proposition for delivering formulations that have rapid onset, with high bioavailability, with precision dosing technology, will be core to our success across key health and wellness categories, including products for pain management, weight management, energy,focus, sleep, anxiety, libido and more. Core to our company’s science are our advanced desiccated liposome formulations and the related international patents for advanced compressible delivery formulations for transmucosal delivery.
MVMD believes its health and wellness success will be bolstered further through intelligent applications ofcannabis-based cannabinoids across its transmucosal delivery product line and other health and wellness products. As such, MVMD also focuses on the areas of cultivation, research and development, and manufacturing across a portfolio of sustainable cannabis assets.
Mountain Valley Strategy
We are working against leading consumer propositions that offer increased bioavailability with rapid onset across the $4.2 trillion health and wellness industry.
MVMD’s advanced desiccated liposome formulations provide transmucosal delivery benefits across leading application categories, including pain management, energy, focus, weight management, sleep, anxiety, and more.
MVMD is working to leverage needleless product delivery evidence from clinical trials to secure licensing deals with key pharma partners across a broad spectrum of molecules.
Our focus on strategic distribution and licensing partnerships in key markets will enable us to leverage our intellectual property, establish supply agreements and monetize our IP rapidly.
Across our delivery sciences IP portfolio, R&D, and our cannabis vertical, MVMD prioritizes investment opportunities on disruptive technologies for health and wellness applications.
Our management team brings together world-class leadership across mucosal delivery sciences, molecular research, IP and legal management, marketing, distribution and financial services.
“The FDA’s Polio D Antigen preservation results demonstrate that Mountain Valley MD’s proprietary and patented Quicksome™ low temperature strip manufacturing technology can be successfully applied to heat labile vaccines, complex proteins such as insulin or glucagon, peptides and other molecules and constructs that are sensitive to heat and oxidation.”
“With encouraging FDA Polio Lab validation, Mountain Valley MD is continuing work on development of our proprietary vaccine adjuvants for Polio and the necessary pre-clinical trials to demonstrate the unprecedented impact of our Quicksome™ technology.”
“For decades scientists have been working to solve the problem of vaccine instability and cold chain distribution with little progress. Approaches such as micro-needle applications, lyophilization, spray drying, and others have not reached commercialization due to problems of complexity, cost, and long-term stability challenges.”
“We believe Mountain Valley MD’s patented Quicksome™ technology revolutionizes drug and nutraceutical ingredient delivery for superior health outcomes by simultaneously addressing a multitude of key drug and nutraceutical product efficacy challenges, such as low bioavailability, high absorption variability and poor dosage control.”
“Many of the active ingredients contained in traditional pharmaceutical drugs and nutraceutical supplements are not well absorbed and suffer extensive degradation during first pass metabolism. We feel this is exactly the problem that Mountain Valley MD’s direct-to-mouth Quicksome™ technology solves, dramatically improving bioavailability of compounds that are traditionally heavily metabolized by MAO enzymes, glucuronidation and other conjugation processes”.
“We have an amazingly talented team that is working on solving some very advanced challenges in the health and wellness space. To date we have done research and development work with more than 60 molecules for a variety of nutraceutical and pharmaceutical applications, including drugs, vaccines, the emerging mushroom space and cannabinoids.”
“For me personally, the idea that our delivery technology could help dispense drugs such as insulin or deliver vaccines into the body through a rapid dissolve sublingual strip and eliminate the need for painful needle injections is truly game changing.”